Rhythm Pharmaceuticals
RYTM
RYTM
115 hedge funds and large institutions have $851M invested in Rhythm Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 25 increasing their positions, 38 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
8% less capital invested
Capital invested by funds: $920M → $851M (-$69M)
34% less repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 38
52% less call options, than puts
Call options by funds: $892K | Put options by funds: $1.86M
Holders
115
Holding in Top 10
2
Calls
$892K
Puts
$1.86M
Top Buyers
| 1 | +$1.96M | |
| 2 | +$1.29M | |
| 3 | +$911K | |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
+$801K |
| 5 |
Primecap Management
Pasadena,
California
|
+$648K |
Top Sellers
| 1 | -$12.4M | |
| 2 | -$5.47M | |
| 3 | -$5.01M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$4.96M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$4.82M |